CDC42 and cancer: AZA197 is a small-molecule inhibitor of the Cdc42-Dbs interaction that was shown to inhibit cancer cell proliferation and invasion with an IC50 of 1–10 μM. AZA197 also reduced tumor growth and extended survival in a mouse model of colon cancer (Zins et al., 2013).